1

The Blue Pill and Big Pharma: A Dangerous Bet?

News Discuss 
The story of Sildenafil offers a intricate case study for investors eyeing drug companies. While early sales were explosive, present patent expiry and the rise of generic versions have considerably influenced earnings. https://zoedbcq332872.blogtov.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story